Nuveen LLC Buys Shares of 120,253 U.S. Physical Therapy, Inc. $USPH

Key Points

• Nuveen LLC has acquired a new stake in U.S. Physical Therapy, purchasing 120,253 shares valued at approximately $8.7 million, representing about 0.79% of the company's total shares.
• The company reported earnings of $0.81 per share, surpassing estimates, with a revenue growth of 18.0% year-over-year, totaling $197.34 million for the quarter.
• U.S. Physical Therapy declared a quarterly dividend of $0.45 per share, with an ex-dividend date of August 22, indicating a strong investment return with a dividend yield of 2.1%.

Nuveen LLC bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 120,253 shares of the company's stock, valued at approximately $8,702,000. Nuveen LLC owned about 0.79% of U.S. Physical Therapy at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Portside Wealth Group LLC grew its stake in shares of U.S. Physical Therapy by 3.9% in the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock valued at $297,000 after purchasing an additional 154 shares during the last quarter. Precision Wealth Strategies LLC grew its stake in shares of U.S. Physical Therapy by 6.6% in the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock valued at $221,000 after purchasing an additional 189 shares during the last quarter. Aquatic Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares during the last quarter. Bessemer Group Inc. grew its stake in shares of U.S. Physical Therapy by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock valued at $357,000 after purchasing an additional 208 shares during the last quarter. Finally, Albert D Mason Inc. grew its stake in shares of U.S. Physical Therapy by 2.5% in the 1st quarter. Albert D Mason Inc. now owns 10,856 shares of the company's stock valued at $786,000 after purchasing an additional 260 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $87.5170 on Friday. The company has a market cap of $1.33 billion, a price-to-earnings ratio of 38.22, a price-to-earnings-growth ratio of 4.47 and a beta of 1.45. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The stock has a 50 day simple moving average of $78.26 and a 200-day simple moving average of $76.83. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.19.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping analysts' consensus estimates of $0.71 by $0.10. The business had revenue of $197.34 million for the quarter, compared to analysts' expectations of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The company's revenue was up 18.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.73 EPS. On average, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a $0.45 dividend. The ex-dividend date is Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.1%. U.S. Physical Therapy's dividend payout ratio is currently 78.60%.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 763 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $84.97, for a total value of $64,832.11. Following the sale, the chief operating officer owned 21,483 shares in the company, valued at $1,825,410.51. This represents a 3.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Nancy Ham sold 400 shares of the company's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director owned 2,594 shares in the company, valued at approximately $202,357.94. This represents a 13.36% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,955 shares of company stock worth $251,170. Insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Barrington Research increased their target price on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Finally, Zacks Research raised U.S. Physical Therapy to a "hold" rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.